Farmacia
Facultat
Corporació Sanitària Parc Taulí
Barcelona, EspañaPublicacions en col·laboració amb investigadors/es de Corporació Sanitària Parc Taulí (17)
2023
-
Importance of immunometabolic markers for the classification of patients with major depressive disorder using machine learning
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 121
2022
-
Current Positioning against Severe Infections Due to Klebsiella pneumoniae in Hospitalized Adults
Antibiotics, Vol. 11, Núm. 9
-
Relationship between immunometabolic status and cognitive performance among major depression disorder patients
Psychoneuroendocrinology, Vol. 137
2021
2019
-
Accuracy of the Narrow-Band Imaging International Colorectal Endoscopic Classification System in Identification of Deep Invasion in Colorectal Polyps
Gastroenterology, Vol. 156, Núm. 1, pp. 75-87
2017
-
Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study
International Journal of Antimicrobial Agents, Vol. 50, Núm. 3, pp. 334-341
-
Individual patterns of complexity in cystic fibrosis lung microbiota, including predator bacteria, over a 1-year period
mBio, Vol. 8, Núm. 5
2016
-
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae
Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 7, pp. 4159-4169
-
Bronchopulmonary infection-colonization patterns in Spanish cystic fibrosis patients: Results from a national multicenter study
Journal of Cystic Fibrosis, Vol. 15, Núm. 3, pp. 357-365
-
Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain
Journal of Infection, Vol. 72, Núm. 2, pp. 152-160
-
Emergence of cfr-mediated linezolid resistance in a methicillin-resistant Staphylococcus aureus epidemic clone isolated from patients with cystic fibrosis
Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 3, pp. 1878-1882
-
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: A multinational pre-registered cohort study
Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 6, pp. 1672-1680
2015
-
Spanish Consensus on the Prevention and Treatment of Pseudomonas aeruginosa Bronchial Infections in Cystic Fibrosis Patients
Archivos de Bronconeumologia, Vol. 51, Núm. 3, pp. 140-150
2014
-
Microbiological diagnostic procedures for respiratory cystic fibrosis samples in Spain: Towards standard of care practices
BMC Microbiology, Vol. 14, Núm. 1
2009
-
Escherichia coli producing SHV-type extended-spectrum β-lactamase is a significant cause of community-acquired infection
Journal of Antimicrobial Chemotherapy, Vol. 63, Núm. 4, pp. 781-784
2008
-
Community infections caused by extended-spectrum β-lactamase-producing Escherichia coli
Archives of Internal Medicine, Vol. 168, Núm. 17, pp. 1897-1902
2003
-
Antibiotic resistance and clinical significance of Haemophilus influenzae type f
Journal of Antimicrobial Chemotherapy, Vol. 52, Núm. 6, pp. 961-966